A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.

Dahai YuJ ShangY CaiZ WangB ZhaoZ ZhaoDavid Simmons

Published in: Diabetic medicine : a journal of the British Diabetic Association (2019)

A total of 15 predictors were significantly associated with newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes. The blood cell model appeared to be the low-cost model with the best predictive ability.

Keyphrases

low cost
diabetic nephropathy
newly diagnosed
type diabetes
ultrasound guided
fine needle aspiration
single cell
cardiovascular disease
cell therapy
insulin resistance
metabolic syndrome
glycemic control